National Institute of Oncology, Hungary

How to interpret these research links

Connected source records

The exact organization name National Institute of Oncology, Hungary appears in 10 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials10

Recruiting shown4

Roles1

SourceClinicalTrials.gov

Clinical trials

10 shown

Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)NCT07067437 · lead sponsor · 2025-07-01

RECRUITING

Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization TechniquesNCT04356235 · lead sponsor · 2020-04-27

RECRUITING

Comparison of the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Round-block and Retroglandular Oncoplastic Breast Conserving SurgeriesNCT04349527 · lead sponsor · 2020-04-18

RECRUITING

Examining the Cosmetic Results, Quality of Life and Patient Satisfaction Achieved With Skin Reducing Nipple Sparing Mastectomy and Implant Based Breast Reconstruction, and Comparing it to Classic Skin- Sparing Mastectomy and Implant- Based Breast Reconstructive SurgeriesNCT04345081 · lead sponsor · 2020-04-18

RECRUITING

Neoadjuvant Treatment of Breast CancerNCT05131893 · lead sponsor · 2022-03-01

NOT_YET_RECRUITING

HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.NCT02258087 · lead sponsor · 2014-09-01

UNKNOWN

Functional Anatomical Examination of Axillary Sentinel Lymph Node Drainage in the Axillary Subregions in Early Breast CancerNCT01804309 · lead sponsor · 2013-03-01

COMPLETED

Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised StudyNCT01509781 · lead sponsor · 2011-09-01

UNKNOWN

Cosmetic and Functional Outcomes After Breast Conserving SurgeryNCT01496001 · lead sponsor · 2011-03-01

COMPLETED

Accelerated Partial Breast Irradiation With 3D-CRT and IMRTNCT02003560 · lead sponsor · 2006-12-01

UNKNOWN

Drugs studied in this sponsor's trials

10 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing National Institute of Oncology, Hungary as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

capecitabine1

cyclophosphamide1

docetaxel1

epirubicin1

goserelin1

letrozole 2.5 MG Oral Tablet1

paclitaxel1

pertuzumab1

Sponsor roles

lead sponsor10

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.